WHO ICTRP trial
Study on the Pharmacokinetic Effect of Omeprazole Magnesium Enteric-coated…
ChiCTR2500108803 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500108803 |
|---|---|
| Public title | Study on the Pharmacokinetic Effect of Omeprazole Magnesium Enteric-coated Tablets on HS-10506 Tablets |
| Scientific title | Study on the Pharmacokinetic Effect of Omeprazole Magnesium Enteric-coated Tablets on HS-10506 Tablets |
| Primary sponsor | The Third Xiangya Hospital Central South University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | China |
| Conditions | Insomnia, depression |
| Interventions | Experimental group:On Day 1 and Day 8 of the trial, HS-10506 tablets were orally administered 60 mg (20 mg/tablet/tablet, 3 tablets) on an empty stomach, and on Day 4~Day 8 of the trial, omeprazole magnesium enteric-coated tablets were… |
| Registration date | Sep 5, 2025 |
| Target size | Experimental group:18 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: